Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field. The most proportion of Drugs for Sinusitis is Orthopedics, Musculoskeletal &Spine. Johnson & Johnson, Sanofi, Dr Reddy's Laboratories etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The report details the trend, potential and market size of Drugs for Sinusitis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Sinusitismarket, defines the market attractiveness level of Drugs for Sinusitis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drugs for Sinusitis industry, describes the types of Drugs for Sinusitis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Sinusitis market and the development prospects and opportunities of Drugs for Sinusitis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Sinusitis market in Chapter 13.
By Player:
Johnson & Johnson
Sanofi
Dr Reddy's Laboratories
Merck
Novartis AG
AstraZeneca Plc
Bionorica SE
Amgen
Huasun
Pfizer
Bayer AG
By Type:
Antibiotics
Corticosteroids
Decongestants
By End-User:
Acute Sinusitis
Chronic Sinusitis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drugs for Sinusitis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drugs for Sinusitis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drugs for Sinusitis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drugs for Sinusitis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drugs for Sinusitis Market Analysis and Outlook to 2022
-
7.1 Global Drugs for Sinusitis Consumption (2017-2022)
-
7.2 United States Drugs for Sinusitis Consumption (2017-2022)
-
7.3 Europe Drugs for Sinusitis Consumption (2017-2022)
-
7.4 China Drugs for Sinusitis Consumption (2017-2022)
-
7.5 Japan Drugs for Sinusitis Consumption (2017-2022)
-
7.6 India Drugs for Sinusitis Consumption (2017-2022)
-
7.7 South Korea Drugs for Sinusitis Consumption (2017-2022)
8 Region and Country-wise Drugs for Sinusitis Market Analysis and Outlook to 2028
-
8.1 Global Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.2 United States Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.3 Europe Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.4 China Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.5 Japan Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.6 India Drugs for Sinusitis Consumption Forecast (2022-2028)
-
8.7 South Korea Drugs for Sinusitis Consumption Forecast (2022-2028)
9 Global Drugs for Sinusitis Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Sinusitis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Decongestants Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Sinusitis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Sinusitis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chronic Sinusitis Consumption and Growth Rate (2017-2022)
10 Global Drugs for Sinusitis Market Outlook by Types and Applications to 2028
-
10.1 Global Drugs for Sinusitis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Decongestants Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drugs for Sinusitis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chronic Sinusitis Consumption Forecast and Growth Rate (2022-2028)
11 Global Drugs for Sinusitis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drugs for Sinusitis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drugs for Sinusitis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drugs for Sinusitis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drugs for Sinusitis Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Drugs for Sinusitis Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Drugs for Sinusitis Product and Service
-
14.3 Dr Reddy's Laboratories
-
14.3.1 Dr Reddy's Laboratories Company Details
-
14.3.2 Dr Reddy's Laboratories Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Dr Reddy's Laboratories Drugs for Sinusitis Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Drugs for Sinusitis Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Drugs for Sinusitis Product and Service
-
14.6 AstraZeneca Plc
-
14.6.1 AstraZeneca Plc Company Details
-
14.6.2 AstraZeneca Plc Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Plc Drugs for Sinusitis Product and Service
-
14.7 Bionorica SE
-
14.7.1 Bionorica SE Company Details
-
14.7.2 Bionorica SE Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bionorica SE Drugs for Sinusitis Product and Service
-
14.8 Amgen
-
14.8.1 Amgen Company Details
-
14.8.2 Amgen Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgen Drugs for Sinusitis Product and Service
-
14.9 Huasun
-
14.9.1 Huasun Company Details
-
14.9.2 Huasun Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Huasun Drugs for Sinusitis Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Drugs for Sinusitis Product and Service
-
14.11 Bayer AG
-
14.11.1 Bayer AG Company Details
-
14.11.2 Bayer AG Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer AG Drugs for Sinusitis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drugs for Sinusitis
-
Figure Drugs for Sinusitis Picture
-
Table Global Drugs for Sinusitis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Sinusitis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Sinusitis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drugs for Sinusitis Consumption by Country (2017-2022)
-
Figure United States Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure China Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Sinusitis Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Decongestants Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Sinusitis Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Decongestants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Sinusitis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drugs for Sinusitis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drugs for Sinusitis Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Drugs for Sinusitis Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Drugs for Sinusitis Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Drugs for Sinusitis Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Sinusitis Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Drugs for Sinusitis Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Drugs for Sinusitis Product and Service
-
Table Bionorica SE (Foundation Year, Company Profile and etc.)
-
Table Bionorica SE Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionorica SE Drugs for Sinusitis Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Drugs for Sinusitis Product and Service
-
Table Huasun (Foundation Year, Company Profile and etc.)
-
Table Huasun Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huasun Drugs for Sinusitis Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drugs for Sinusitis Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Drugs for Sinusitis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Drugs for Sinusitis Product and Service
-
